Indolent T-Cell Non-Hodgkin Lymphoma
generalA T-cell non-Hodgkin lymphoma with an indolent clinical course.
15
Centers
17
Active Trials
$4.8B
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Subcutaneous Panniculitis-Like T-Cell Lymphoma | 15 |
Top Centers for Indolent T-Cell Non-Hodgkin Lymphoma(15)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | — |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | — |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | — |
| 4 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | — |
| 5 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | — |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | — |
| 7 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | — |
| 8 | NCI Clinical | — |
| 9 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive | — |
| 10 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | — |
| 11 | University of Illinois Cancer CenterChicago, IL | — |
| 12 | Boston University Cancer CenterBoston, MA | — |
| 13 | Cancer Center at IllinoisUrbana, IL | — |
| 14 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ | — |
| 15 | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →